Approaches to interim monitoring
At the time point of interim analysis in a phase II clinical trial, the key question that is addressed is: Is the trial sufficiently likely to achieve its goal based on the data observed so far, or should the trial be stopped for futility? There exist two frameworks that are both naturally suited to answer this question: the CP